Tirzepatide Use in People With Obesity and Type 1 Diabetes
Abroad (travel likely)RecruitingPHASE4
Conditions
Type1diabetes · Obesity
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Dasman Diabetes Institute, Kuwait City, Sharq, Kuwait
Contact: Study coordinator (Shaikhah M Alghanim, Masters) · shaikhah.alghanim@dasmaninstitute.org · 1877877Contact: Principal Investigator (Ebaa Al Ozairi, MD)
Study leads
Ebaa Al Ozairi, MD
Principal Investigator
Dasman Diabetes Institute